Tohru Ishikawa

Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer Xenografts

Tohru Ishikawa, Masahiro Utoh, Noriaki Sawada et al. · Biochemical Pharmacology · 1998 · 329 citations

Oncology, Polymer-drug Conjugate, Medicine +10

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.

Tohru Ishikawa, Fumiko Sekiguchi, Yu Fukase et al. · PubMed · 1998 · 304 citations

Chemoprevention Strategy, Pathology, Human Cancer Xenografts +16

Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma

Satoru Shintani, Chunnan Li, Tohru Ishikawa et al. · Oral Oncology · 2003 · 131 citations

Tumor Biology, Oncology, Angiogenesis +10

Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5?-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models

Mika Endo, Noriko Shinbori, Yu Fukase et al. · International Journal of Cancer · 1999 · 129 citations · Full text

Tumor Biology, Breast Oncology, Oncology +15

CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma

Tohru Ishikawa, Koh‐ichi Nakashiro, Shingo Hara et al. · International Journal of Oncology · 2006 · 91 citations · Full text

Oncology, Malignant Disease, Lymph-node Metastasis +15